Intra-lesional 5 fluorouracil for the management of recurrent pterygium
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2013/06/28
-
Journal
-
Indian UGC (journal)
-
Refrences29
-
Citations19
-
D G Said
-
L A Faraj
-
M S Elalfy
-
A Yeung
-
A Miri
-
U Fares
-
A M Otri
-
I Rahman
-
S Maharajan
-
H S Dua
Cite
Said, D G, et al. “Intra-Lesional 5 Fluorouracil for the Management of Recurrent Pterygium”. Eye, vol. 27, no. 10, 2013, pp. 1123-9, https://doi.org/10.1038/eye.2013.135.
Said, D. G., Faraj, L. A., Elalfy, M. S., Yeung, A., Miri, A., Fares, U., Otri, A. M., Rahman, I., Maharajan, S., & Dua, H. S. (2013). Intra-lesional 5 fluorouracil for the management of recurrent pterygium. Eye, 27(10), 1123-1129. https://doi.org/10.1038/eye.2013.135
Said, D G, L A Faraj, M S Elalfy, A Yeung, A Miri, U Fares, A M Otri, I Rahman, S Maharajan, and H S Dua. “Intra-Lesional 5 Fluorouracil for the Management of Recurrent Pterygium”. Eye 27, no. 10 (2013): 1123-29. https://doi.org/10.1038/eye.2013.135.
Said DG, Faraj LA, Elalfy MS, Yeung A, Miri A, Fares U, et al. Intra-lesional 5 fluorouracil for the management of recurrent pterygium. Eye. 2013;27(10):1123-9.
Journal Categories
Medicine
Medicine (General)
Medicine
Ophthalmology
You May Also Like
- Comparison of immersion ultrasound biometry and partial coherence interferometry for intraocular lens calculation according to Haigis
- Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT)
- Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)
- The Pathogenesis of Edema in Diabetic Maculopathy
- Ocular Manifestations and Treatment of Syphilis
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| 10.1097/ICO.0b013e3182151e0e | Cornea |
| 2012 | |
| Comparison of Fibrin Glue versus Suture for Conjunctival Autografting in Pterygium Surgery: A Meta-Analysis | Ophthalmology |
| 66 | 2011 |
| 10.1097/ICO.0b013e3181b11630 | Cornea |
| 2010 | |
| The Singapore 5-Fluorouracil Trabeculectomy Study | Ophthalmology |
| 58 | 2009 |
| 10.1097/ICO.0b013e3181822615 | Cornea |
| 2009 |
Refrences Analysis
The category
Medicine: Medicine (General) 13
is the most frequently represented among the references in this article. It primarily includes studies from Ophthalmology and Cornea. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Modulation Agents of Wound Healing in Ocular Surgeries | JANUARY 2024 | 2024 | ||
Modified Limbal–Conjunctival Autograft Surgical Technique: Long-Term Results of Recurrence and Complications | Cornea |
| 2023 | |
| Rapid 3D bioprinting of a multicellular model recapitulating pterygium microenvironment | Biomaterials |
| 12 | 2022 |
| 5-Fluorouracil in primary, impending recurrent and recurrent pterygium: Systematic review of the efficacy and safety of a surgical adjuvant and intralesional antimetabolite | The Ocular Surface |
| 8 | 2022 |
| Recurrent pterygium: A review | Journal of Current Ophthalmology |
| 10 | 2021 |
Citations Analysis
The category
Medicine: Ophthalmology 12
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Molecular Basis of Pterygium Development and was published in 2014. The most recent citation comes from a 2024 study titled Modulation Agents of Wound Healing in Ocular Surgeries. This article reached its peak citation in 2018, with 3 citations. It has been cited in 16 different journals. Among related journals, the Cornea cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.